Intuitive Surgical Inc
ISRG451.580USD
-43.030-8.70%
Fechamento 04/04, 16:00（ET）Cotações atrasadas em 15 min
161.03BValor de mercado
69.33P/L TTM
Informações de Intuitive Surgical Inc Empresa
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Informações da empresa
Código da empresaISRG
Nome da EmpresaIntuitive Surgical Inc
Data de listagemJun 13, 2000
Fundado em1995
CEODr. Gary S. Guthart, Ph.D.
Funcionários15638
Tipo de TítulosOrdinary Share
Fim do ano fiscalJun 13
Endereço1020 Kifer Road
CidadeSUNNYVALE
Bolsa de ValoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94086
Telefone14085232100
Sitehttps://www.intuitive.com/en-us/about-us/company
Código da empresaISRG
Data de listagemJun 13, 2000
Fundado em1995
Executivos da Empresa
Nome
Nome/Posição
Posição
Ações Detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
2.04K
-54.69%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
1.61K
--
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
671.00
-18.27%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
240.00
--
Ver Mais
Nome
Nome/Posição
Posição
Ações Detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.27M
+1.05%
Mr. David J. Rosa
Mr. David J. Rosa
President, Director
President, Director
231.87K
+5.81%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
12.28K
--
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
2.37K
--
Detalhamento da Receita
Moeda: USDTempo de atualização: qua, 2 de abr
Moeda: USDTempo de atualização: qua, 2 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Por RegiãoUSD
Nome
Receita
Proporção
U.S.
5.59B
66.92%
Outside of United states
2.76B
33.08%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
5.08B
60.81%
Systems
1.97B
23.54%
Services
1.31B
15.65%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas do Acionista
Tipo
Estatísticas do Acionista
Acionista
Proporção
The Vanguard Group, Inc.
8.95%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.90%
Fidelity Management & Research Company LLC
2.93%
Other
74.77%
Estatísticas do Acionista
Acionista
Proporção
The Vanguard Group, Inc.
8.95%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Global Advisors (US)
4.27%
T. Rowe Price Associates, Inc.
3.90%
Fidelity Management & Research Company LLC
2.93%
Other
74.77%
Tipo
Acionista
Proporção
Investment Advisor
43.07%
Investment Advisor/Hedge Fund
35.61%
Bank and Trust
2.46%
Research Firm
2.40%
Pension Fund
2.20%
Hedge Fund
1.76%
Sovereign Wealth Fund
1.39%
Individual Investor
0.50%
Foundation
0.15%
Other
10.46%
Instituição Participações
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do Relatório
Nº de instituições
Ações detidas
Proporção
Variação
2025Q1
3377
322.64M
90.05%
-654.22K
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
2022Q4
2840
310.11M
87.74%
-7.77M
Ver Mais
Atividade dos Acionistas
Nome
Ações detidas
Proporção
Variação
Chg %
Data
The Vanguard Group, Inc.
32.06M
8.95%
+364.96K
+1.15%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
18.57M
5.18%
+488.70K
+2.70%
Dec 31, 2024
State Street Global Advisors (US)
15.31M
4.27%
+255.30K
+1.70%
Dec 31, 2024
T. Rowe Price Associates, Inc.
13.96M
3.9%
-133.51K
-0.95%
Dec 31, 2024
Fidelity Management & Research Company LLC
10.49M
2.93%
-117.40K
-1.11%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.76M
2.17%
+243.80K
+3.25%
Dec 31, 2024
Capital World Investors
7.43M
2.07%
+11.93K
+0.16%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
7.37M
2.06%
+98.84K
+1.36%
Feb 28, 2025
JP Morgan Asset Management
7.22M
2.01%
+123.15K
+1.74%
Dec 31, 2024
Fisher Investments
4.87M
1.36%
+86.49K
+1.81%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: ter, 1 de abr
Tempo de atualização: ter, 1 de abr
Nome
Proporção
Langar Global HealthTech ETF
19.52%
iShares U.S. Medical Devices ETF
16.03%
Global X Robotics & Artificial Intelligence ETF
11.55%
First Trust Nasdaq Lux Digi Health Solutions ETF
8.42%
Invesco AI and Next Gen Software ETF
7.04%
Franklin Intelligent Machines ETF
6.73%
Goldman Sachs Future Health Care Equity ETF
6.3%
Neuberger Berman Disrupters ETF
6.01%
Inspire 100 ETF
5.52%
iShares Health Innovation Active ETF
5.34%
Ver Mais
Langar Global HealthTech ETF
Proporção19.52%
iShares U.S. Medical Devices ETF
Proporção16.03%
Global X Robotics & Artificial Intelligence ETF
Proporção11.55%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção8.42%
Invesco AI and Next Gen Software ETF
Proporção7.04%
Franklin Intelligent Machines ETF
Proporção6.73%
Goldman Sachs Future Health Care Equity ETF
Proporção6.3%
Neuberger Berman Disrupters ETF
Proporção6.01%
Inspire 100 ETF
Proporção5.52%
iShares Health Innovation Active ETF
Proporção5.34%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro das ações
Data de pagamento
Data de ex-dividendo
Sem dados
Desdobramento de Ações
Data
Tipo
Proporção
Aug 05, 2021
Split
1>3
Data
Tipo
Proporção
Aug 05, 2021
Split
1>3